FIELD: medicine.
SUBSTANCE: invention refers to medicine, more specifically to a method for making a preparation for transdermal nicotine introduction, which involves the stage of formation on a substrate of an adhesive layer containing an adhesive and a liquid component compatible with the adhesive, and the stage of nicotine impregnation of the adhesive layer by continuous coating of the adhesive layer.
EFFECT: invention provides direct application of nicotine on the adhesive layer that is impracticable by conventional methods, and application of the preparation for transdermal nicotine introduction prepared by the method is associated with lesser physical skin irritation when removed and provides a pleasant sensation during gluing on.
5 cl, 4 dwg, 9 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PREPARATION FOR TRANSDERMAL NICOTINE INTRODUCTION AND METHOD FOR MAKING THEREOF | 2006 |
|
RU2407516C2 |
| NICOTINE TRANSDERMAL DELIVERY SYSTEM | 2006 |
|
RU2400216C2 |
| SYSTEMS AND METHODS FOR PROLONGED TRANSDERMAL INTRODUCTION | 2016 |
|
RU2737464C2 |
| DEVICE FOR PREPARING SKIN-ABSORBABLE PREPARATION | 2007 |
|
RU2432148C2 |
| METHOD AND TRANSDERMAL THERAPEUTIC SYSTEM FOR EXERTING SEDATIVE INFLUENCE UPON PATIENT | 1992 |
|
RU2098083C1 |
| DEVICE FOR TRANSDERMAL BISOPROLOL INTRODUCTION | 2008 |
|
RU2440811C2 |
| DONEPEZIL-CONTAINING ADHESIVE MEDICATION AND PACKAGE FOR IT | 2009 |
|
RU2481826C2 |
| ADHESIVE PREPARATION CONTAINING BISOPROLOL | 2016 |
|
RU2725071C2 |
| TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING LAVAND OIL | 2015 |
|
RU2695785C2 |
| ANTICANCER VACCINE COMPOSITION CONTAINING PEPTIDE WT1 FOR TRANSDERMAL ADMINISTRATION | 2014 |
|
RU2685933C2 |
